)
Elevance Health (ELV) investor relations material
Elevance Health Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
2026 is positioned as a year of execution and repositioning, focusing on pricing discipline, operational rigor, and targeted investments to strengthen margins and reduce volatility, with an emphasis on Medicare margin improvement and managing Medicaid headwinds.
Fourth quarter and full year 2025 operational results were consistent with expectations, with adjusted diluted EPS of $3.33 for Q4 and $30.29 for the year, including $3.75 of non-recurring favorable items, mainly tax-related benefits.
Operating revenue for 2025 grew 13% to $197.6B, driven by improved premium yields, acquisitions, and Medicare Advantage growth, partially offset by Medicaid attrition.
Strategic priorities include care coordination, analytics-driven cost management, and investments in digital and AI-enabled capabilities.
Returned $4.1B to shareholders in 2025 through share repurchases and dividends.
Financial highlights
Adjusted diluted EPS for Q4 2025 was $3.33 and $30.29 for the full year, with 2026 guidance at least $25.50; 2025 results included $3.75 per share of non-recurring items.
Operating revenue for Q4 2025 was $49.3B, up 10% year-over-year; full year 2025 revenue was $197.6B, up 13%.
Full-year operating cash flow was $4.3B, with 2026 expected to be at least $5.5B.
2025 benefit expense ratio increased 150 bps to 90.0%, reflecting higher cost trends across all major lines.
2025 adjusted operating expense ratio improved to 10.5% due to disciplined expense management.
Outlook and guidance
2026 adjusted EPS guidance is at least $25.50, with a return to at least 12% adjusted EPS growth expected in 2027.
Operating revenue is expected to decline in the low single-digit % range in 2026, mainly due to a low double-digit % decline in risk-based membership.
Consolidated medical loss ratio for 2026 is expected at 90.2% ±50 bps; adjusted operating expense ratio at 10.6% ±50 bps.
Approximately two-thirds of 2026 adjusted EPS is expected in the first half, with 65% in Q1.
Total medical membership expected to decline to 43.2–43.9 million in 2026.
- TimeTickerHeadlineOpen
- 323410
Strong growth in customers, profits, and deposits, with stable asset quality and global milestones. - 3407
Net income rose 22.7% year-over-year, with improved financials and a revised upward forecast. - RYM
Refreshed strategy targets NZD 150m cash flow uplift, NZD 500m cash release, and resumed dividends by FY 2028. - 9101
Profits fell across most segments, but energy shipping and a major acquisition stood out. - 4626
Double-digit profit and sales growth, with strong segment results and a stock split impact. - 2371
Revenue up 21.5% YoY, but profit down on higher investments; LiPLUS Holdings acquired. - 3401
Major impairments and divestitures led to a net loss and lower revenue across all segments. - 8002
Profit forecast raised to ¥540.0B and annual dividend to ¥107.50 per share after strong results. - COF
Profit rebounded, NTA and occupancy rose, with strong leasing and premium divestment. - NUF
Statutory loss reported, seeds business repositioned, new CEO appointed, all resolutions passed.
Next Elevance Health earnings date
Next Elevance Health earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)